Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
NCT03941184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114
Last updated 2020-11-23
Summary
This case control study aims to determine whether spontaneous coronary artery dissection (SCAD) is associated with autoimmune diseases and to update the incidence of SCAD in a population-based cohort.
Conditions
- SCAD
- Addison Disease
- Ankylosing Spondylitis
- Antiphospholipid Antibody Syndrome
- Celiac Disease
- Crohn Disease
- Dermatomyositis
- Polymyositis
- Guillain-Barre Syndrome
- Hepatitis, Autoimmune
- Graves Disease
- Hashimoto Thyroiditis
- Multiple Sclerosis
- Myasthenia Gravis
- Pernicious Anemia
- Polymyalgia Rheumatica
- Primary Biliary Cirrhosis
- Psoriasis
- Rheumatoid Arthritis
- Systemic Sclerosis
- Sjögren Syndrome
- Systemic Lupus Erythematosus
- Takayasu Arteritis
- Type 1 Diabetes Mellitus
- Ulcerative Colitis
- Uveitis
- Vasculitis
- Vitiligo
- Raynaud
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-01-01
- Primary Completion
- 2020-11-10
- Completion
- 2020-11-10
Countries
- United States
Study Locations
More Related Trials
-
Lymphocyte Sub-populations and Auto Immune Diseases
NCT03901664 ·Status: COMPLETED
-
Scrutinizing the Heterogeneity of SLE: Defining Phenotypes
NCT03348774 ·Status: UNKNOWN
-
The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice
NCT04558203 ·Status: COMPLETED
-
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
NCT05022420 ·Status: RECRUITING
-
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders
NCT07037732 ·Status: RECRUITING
-
Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance
NCT01180361 ·Status: COMPLETED
-
Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease
NCT06324578 ·Status: RECRUITING
-
Systemic Lupus Erythematous and Heart Conduction Disorders
NCT02162992 ·Status: COMPLETED
-
FolateScan in Autoimmune Disease
NCT00588393 ·Status: COMPLETED ·Phase: PHASE2
-
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
NCT00189124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Immunome Project Consortium for Autoinflammatory Disorders
NCT03919110 ·Status: COMPLETED
-
Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
NCT03254823 ·Status: COMPLETED
-
Monitoring the IMmUological TOXicity of Drugs
NCT03480529 ·Status: COMPLETED
-
Catalytic Antibodies and Lupus in Martinique
NCT01157468 ·Status: COMPLETED
-
Prevalence of Peripheral Vascular Diseases and Presentation in Patients With Autoimmune Diseases
NCT06169865 ·Status: RECRUITING
-
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
NCT06977724 ·Status: RECRUITING ·Phase: PHASE1
-
An Observational Study of Patients With Autoimmune Disease
NCT05842824 ·Status: NOT_YET_RECRUITING
-
Neutrophil Extracellular Traps in Systemic Sclerosis
NCT03374618 ·Status: COMPLETED ·Phase: NA
-
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
NCT05843643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
NCT00610805 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
NCT03951259 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
NCT02890134 ·Status: COMPLETED
-
Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases
NCT04690816 ·Status: COMPLETED
-
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
NCT02725515 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
NCT06828042 ·Status: RECRUITING ·Phase: PHASE1/PHASE2